Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adapt, adjudicated, AgainstDiffuseAggressiveLymphoma, BackboneTreatmentsofMultiple, breakdown, bridge, cardiac, Celegene, chromosome, compelling, concert, corticospinal, CRi, Danish, Deepika, deletion, Eli, enasidenib, epilepsy, epileptic, ESMO, exploration, explore, febrile, FileNo, FN, India, isatuximab, isolate, Jazz, lift, lifted, lifting, linked, modification, MRD, narrative, neuropathy, nonhematologic, Notably, online, pain, pamolidomide, PC, PCs, perfunctory, Ph, pilocarpine, poster, preatreated, precisely, qualitative, quantitative, Radiological, reconciling, reiterated, robust, RSV, SDd, SELHEM, sequellae, signifying, Singapore, SLE, SPd, subgroup, SVd, syncytial, tAML, treatable, TreatmentofRefractoryMyeloma, true, undertaken, underway, unused, Vd, visit, warranting, washout
Filing tables
Filing exhibits
Related press release
KPTI similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Karyopharm Therapeutics Inc.
Jurisdiction of Incorporation or Organization | ||
Karyopharm Securities Corp. | Massachusetts | |
Karyopharm Europe GmbH | Germany | |
Karyopharm Therapeutics (Bermuda) Ltd. | Bermuda |